During development, neurons pass through a critical phase in which survival
is dependent on neurotrophin support. In order to dissect the potential ro
le of p75(NTR), the common neurotrophin receptor, in neurotrophin dependenc
e, we expressed wild-type and mutant p75(NTR) in cells that do not express
endogenous p75(NTR) Or Trk family members (NIH3T3), Expression of wild-type
p75(NTR) created a state of neurotrophin dependence: cells could be rescue
d by nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF), o
r neurotrophin-3 (NT-3), but not by a mutant NGF that binds well to Trk A b
ut poorly to p75(NTR), Similarly, expression of p75(NTR) in human prostate
cancer cells in culture rendered a metastatic tumor cell line (PC-3) sensit
ive to the availability of neurotrophins for survival. Moreover, expression
of mutant p75(NTR)'s in another neurotrophin-insensitive cell line (HEK293
T) showed that a domain within the intracellular domain governs alternate r
esponses to neurotrophins: the carboxy terminus of the intracellular domain
of p75(NTR) including the sixth alpha helix domain is necessary for rescue
by BDNF, but not NGF, These results, when considered with previous studies
of the timing of p75(NTR) expression, support the hypothesis that p75(NTR)
is a mediator of neurotrophin dependence during the critical phase of deve
lopmental cell death and during the progression of carcinogenesis in prosta
te cancer.